英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

modernist    音标拼音: [m'ɑdɚnəst]
n. 现代主义者,现代人,近代主义者

现代主义者,现代人,近代主义者

modernist
n 1: an artist who makes a deliberate break with previous styles

Modernist \Mod"ern*ist\, n. [Cf. F. moderniste.]
1. One who admires the moderns, or their ways and fashions.
[1913 Webster]

2. An advocate of the teaching of modern subjects, as modern
languages, in preference to the ancient classics.
[Webster 1913 Suppl.]

64 Moby Thesaurus words for "modernist":
Meistersinger, Parnassian, Young Turk, arch-poet, arriviste,
ballad maker, balladmonger, bard, beat poet, bright young man,
bucoliast, comer, elegist, epic poet, fili, fledgling, idyllist,
imagist, jongleur, laureate, librettist, major poet, maker,
minnesinger, minor poet, minstrel, modern, modern generation,
modern man, modernizer, neologism, neologist, neology, neonate,
neoteric, neoterism, neoterist, new generation, new man,
nouveau riche, novus homo, occasional poet, odist, parvenu,
pastoral poet, pastoralist, poet, poet laureate, poetress,
rhapsode, rhapsodist, rising generation, satirist, scop, skald,
sonneteer, stripling, symbolist, troubadour, trouveur, trovatore,
upstart, vers libriste, vers-librist


请选择你想看的字典辞典：
单词字典翻译
Modernist查看　Modernist　在百度字典中的解释百度英翻中〔查看〕
Modernist查看　Modernist　在Google字典中的解释Google英翻中〔查看〕
Modernist查看　Modernist　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Understanding immune checkpoints and PD-1 PD-L1-mediated . . .
    Abstract Immunotherapy has emerged as a transformative approach in the treatment of various cancers, offering new hope for patients previously faced with limited treatment options A cornerstone of cancer immunotherapy lies in targeting immune checkpoints, particularly the programmed cell death protein-1 (PD-1) and programmed death-ligand 1 (PD-L1) pathway Immune checkpoints serve as crucial
  • Immune Checkpoint Inhibitors - NCI - National Cancer Institute
    Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins Learn about the cancers treated with checkpoint inhibitors and the side effects they may cause
  • PD-1 and PD-L1 inhibitors - Wikipedia
    The concept of blocking PD-1 and PD-L1 for the treatment of cancer was first published in 2001 [6] Pharmaceutical companies began attempting to develop drugs to block these molecules, and the first clinical trial was launched in 2006, evaluating nivolumab As of 2017, more than 500 clinical trials involving PD-1 and PD-L1 inhibitors have been conducted in more than 20,000 patients [7] By the
  • PD-L1 and PD-1: Immunotherapy Checkpoint Inhibitors
    A type of cancer immunotherapy targets PD-1 or PD-L1 with checkpoint inhibitors designed to block one or the other Learn more about testing and results
  • Immune Checkpoint Inhibitors and Their Side Effects
    Immune checkpoint inhibitors, like PD-1 or PD-L1 inhibitors, are treatments that help the immune system recognize and attack cancer cells Learn more here
  • Understanding PD-1 and PD-L1 in Cancer Immunotherapy
    Understanding the role of PD-1 and PD-L1 in cancer is essential to comprehend current immunotherapy strategies PD-1, a checkpoint protein on T-cells, and PD-L1, its ligand found on tumor cells, have significant implications for immune response regulation
  • Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity . . .
    Most cancer patients respond transiently to immunotherapy, highlighting the importance of understanding the mechanisms underlying resistance Tichet et al reveal that the immunocytokine PD1-IL2v combined with anti-PD-L1 synergize to enable anti-tumor immunity against immunotherapy-resistant tumors PD1-IL2v promotes stem-like, tumor-reactive CD8+ T cell expansion and high endothelial venule
  • Targeting PD-1 PD-L1 in tumor immunotherapy: Mechanisms and . . .
    Tumor immunotherapy has garnered considerable attention, emerging as a new standard of care in cancer treatment The conventional targets, such as VEGF and EGFR, have been extended to others including BRAF and PD-1 PD-L1, which have shown significant potential in recent cancer treatments
  • Use of PD-1 vs PD-L1 Inhibitors in Patients With Cancer
    This systematic review and meta-analysis of randomized clinical trials examines use of programmed cell death 1 (PD-1) vs programmed cell death–ligand 1 (PD-L1) treatment in patients with cancer
  • Assessing the Pharmacological and Pharmacogenomic Data of PD . . .
    Background Objectives: Advances in understanding immune checkpoint pathways and tumor immune biology have enabled the development of immune checkpoint inhibitors (ICIs), particularly targeting the PD-1 PD-L1 axis, which has transformed cancer immunotherapy While they have shown remarkable success in various cancer types, including melanoma, non-small cell lung cancer, and gastrointestinal





中文字典-英文字典  2005-2009